NeurologyLive® Year in Review 2024: Most-Watched Video Series

Throughout the course of the year, the NeurologyLive^® team hosted panel discussions, peer-to-peer conversations, and other expert-led video programs covering a variety of neurologic topics. Over the course of 2024, our editorial and home-base studio teams produced 25 multiepisode series, featuring dozens of key opinion leaders in neurology patient care.

Among those conversations included discussions about new treatment options and methologies to treat movement disorders, neuromuscular disease, demyelinating diseases, sleep disorders, and many more. Each episode features 5 to 10 minutes of engaging peer-to-peer discussion designed to educate others on the latest and best ways to approach patient care.

Here, we'll highlight just some the most-watched series on NeurologyLive^® this year. Click the buttons to read further into these conversations.

1. CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis

Expert thought leaders Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC; Tanuja Chitnis, MD; and Ahmed Obeidat, MD, PhD, review the latest data and trends regarding the use of neurofilament light chain and other biomarkers in MS diagnosis and treatment.

2. Managing Spinal Muscular Atrophy in Adult Patients

Lauren Elman, MD; Arun Varadhachary, MD, PhD; Thomas Crawford, MD; Julie Parsons, MD, and Crystal Proud, MD, provide valuable insights into the distinct clinical features of pediatric and adult SMA, the complex process of transitioning patients from pediatric to adult healthcare services, and the importance of effectively counseling patients on available treatment options and setting realistic expectations for treatment success.

3. Treatment Advances in Targeting Underlying Pathophysiology of Myasthenia Gravis

Experts Nicholas J. Silvestri, MD, FAAN; Ali A. Habib, MD; Neelam Goyal, MD; and Katherine Ruzhansky, MD, MS, explore the multifaceted aspects of generalized myasthenia gravis, from its clinical presentation and diagnosis to emerging targeted therapies, emphasizing the importance of personalized treatment approaches, discussing recent clinical trial data, and addressing ongoing challenges in both adult and pediatric populations.

4. Preparing for a New Era in Alzheimer's Disease: Debating New Targeted Biomarkers and Therapeutic Approaches

Medical experts Richard Isaacson, MD; Sharon Cohen, MD, FRCPC; and Marwan Sabbagh, MD, discuss the criticality of early intervention and evolving treatment strategies surrounding Alzheimer’s disease.

5. Effective Management of Excessive Daytime Sleepiness and Narcolepsy

In this program, experts in sleep medicine Michael J. Thorpy, MD; Karl Doghramji, MD; Clete Kushida, MD, PhD; and Richard Bogan, MD, FCCP, FAASM, focus on the treatment and management of excessive daytime sleepiness in narcolepsy. Together, they discuss patient selection criteria for available treatment options and guidance on switching therapies in narcolepsy.

6. Special Report: IPX203 as New Treatment for Parkinson Disease

Movement disorder experts Robert Hauser, MD, MBA, and Hubert Fernandez, MD, discuss the recently approved IPX203 (Crexont; Amneal Pharmaceuticals) for the treatment of patients with Parkinson disease.

7. Multimodal Actions of S1P Receptor Modulators in Multiple Sclerosis

Multiple sclerosis experts Patricia Coyle, MD, FAAN, and Adnan Subei, DO, FAAN, cover the long-term impacts of S1P-modulating treatments for MS, the differences in each treatment, and how the class has evolved since the first therapeutic over 10 years ago.

8. The Role of Genetic Testing on the Management Pediatric Epilepsy

John Michael Schreiber, MD, discusses how genetic testing enhances the diagnosis and management of pediatric epilepsy, emphasizing its importance in tailoring treatment strategies for affected patients.

9. Expert Insights on Novel NMOSD Treatments

Three medical experts—Michael Levy, MD, PhD; Jacqueline Nicholas, MD, MPH; and Sean Pittock, MD—explore key insights on novel treatments for NMOSD, focusing on relapse management, disability accumulation, and the efficacy of new versus traditional therapies.

10. Expert Perspectives on Dravet Syndrome Management

Scott Perry, MD, discusses how Dravet syndrome, a rare genetic epilepsy, presents significant challenges in diagnosis, treatment, and management, emphasizing the importance of early detection, comprehensive care strategies, and support for both patients and caregivers to optimize outcomes and quality of life.